Latest Synthetic Blood International Inc. Stories
Effective today, Oxygen Biotherapeutics, Inc. is the new name for the company previously known as Synthetic Blood International, Inc. (OTCBB:SYBD). Effective with the opening of trading today, the company's new trading symbol will be OXBO.
Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that grants awarded by the Department of Defense to study clinical applications for Oxycyte(R) total more than $5.3 million. Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that the company's shareholders have approved the proposals put before them at a special shareholders meeting that was held today. The proposals include changing the name of the company to Oxygen Biotherapeutics, Inc.
- an ornament or knob in the shape of a flower